2565
We report the case of a 14-year-old female with acute promyelocytic leukemia who developed symptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and all-trans retinoic acid (ATRA).
 ( adverse event: developed ,  a 14-year-old female with acute promyelocytic leukemia: Subject, 14-year-old: Subject.Age, female: Subject.Gender, symptomatic cardiomyopathy: Effect, 4 months into treatment with a combination of daunomycin and all-trans retinoic acid (ATRA): Treatment, acute promyelocytic leukemia: Treatment.Disorder, 4 months: Treatment.Time_elapsed, daunomycin: Treatment.Drug, all-trans retinoic acid: Treatment.Drug, daunomycin: Combination.Drug, all-trans retinoic acid: Combination.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: developed ,  a 14-year-old female with acute promyelocytic leukemia: Subject, 14-year-old: Subject.Age, female: Subject.Gender, symptomatic cardiomyopathy: Effect, 4 months into treatment with a combination of daunomycin and all-trans retinoic acid (ATRA): Treatment, acute promyelocytic leukemia: Treatment.Disorder, 4 months: Treatment.Time_elapsed, daunomycin: Treatment.Drug, all-trans retinoic acid: Treatment.Drug, daunomycin: Combination.Drug, all-trans retinoic acid: Combination.Drug) 